Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Amicus Therapeutics logo — Our passion for making a difference unites us.

Amicus Therapeutics

Our passion for making a difference unites us.

Founded 2002 United States Princeton, United States 604 employees Post Ipo Debt Total: $2.30B Biotechnology, Health Care +2

General Information

Company Name Amicus Therapeutics
Founded Year 2002
Location United States Princeton, United States +9
Founders / Decision Makers
Team member Team member
Employees 604
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Post Ipo Debt
Social

Get notified when Amicus Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Amicus Therapeutics

Amicus Therapeutics is a global, patient-dedicated biotechnology company founded in 2002 and headquartered in the United States. The company's slogan, "Our passion for making a difference unites us," reflects its commitment to discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. The company's name, Amicus, reflects its collaborative approach to developing medicines, incorporating the patient perspective at every step. Founded by an entrepreneur driven by a personal experience with rare disease, the company's culture is characterized by empathy, compassion, and tenacity. Amicus's mission-focused behaviors drive its performance and innovation, shaping its culture and attracting top talent. The company's recent investment of $30.00MPost-IPO Equity at 02 October 2023 was led by Blackstone Life Sciences. With a global footprint spanning over 20 countries, Amicus is committed to pushing the boundaries of medical innovation. More information about Amicus and their career opportunities can be found at www.amicusrx.com.

Taxonomy: pharmaceuticals, rare diseases, patient-centered, global footprint, innovation, drug discovery, medicine delivery, entrepreneurship, compassion, mission-driven, global headquarters, international presence, career opportunities

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1 •••• •••• 02 Oct 2023
Post-IPO Equity •••••• 1 •••• •••• 02 Oct 2023
Post-IPO Debt •••••• 1 •••• •••• 17 Jul 2020
Post-IPO Equity •••••• - 04 Jun 2019
Post-IPO Equity •••••• - 16 Feb 2018

View All 15 Funding Rounds

Amicus Therapeutics Alternatives & Competitors

Amicus Therapeutics vs
Scioderm, Inc., an Amicus Therapeutics Company
Scioderm, Inc., an Amicus Therapeutics Company United States

Dedicated to pioneering topical solutions for treating chronic skin diseases.

Series B
2 employees
Biotechnology, Health Care
Compare Amicus Therapeutics vs Scioderm, Inc., an Amicus Therapeutics Company
Amicus Therapeutics vs
Sanius Health
Sanius Health United Kingdom

Sanius Health is a patient-owned company which focuses primarily on patients living with Sickle Cell...

26 employees
Health Care, Mobile
Compare Amicus Therapeutics vs Sanius Health
Amicus Therapeutics vs
ViiV Healthcare
ViiV Healthcare United Kingdom

We are ViiV Healthcare. Here until HIV & AIDS aren't.

1848 employees
Biotechnology, Health Care
Compare Amicus Therapeutics vs ViiV Healthcare

FAQ About Amicus Therapeutics

Our passion for making a difference unites us.
Amicus Therapeutics was founded in 2002.
Amicus Therapeutics is headquartered in Princeton, United States.
Amicus Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Amicus Therapeutics has approximately 604 employees.
Amicus Therapeutics has completed 15 funding rounds, raising a total of $2.30B. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Amicus Therapeutics include Scioderm, Inc., an Amicus Therapeutics Company, Sanius Health, ViiV Healthcare, Synageva BioPharma Corp., Novique Life Sciences Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amicus Therapeutics and Scioderm, Inc., an Amicus Therapeutics Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Amicus Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy